Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer

Clinical trial NCT03258008 · TERMINATED

Trial details

NCT number: NCT03258008
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites Malignant Neoplasms of Lip Oral Cavity and Pharynx Oropharyngeal Cancer

Start date: 2018-04-04
Primary completion: 2021-11-05
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.